Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
Wall Street Journal
Bristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint.
https://www.wsj.com/articles/bristol-myers-squibb-cancer-treatment-trial-misses-endpoint-69d95740